Fab fragment of Humanized anti-viral antibody MEDI-493 (Synagis TM)
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| A [auth L] | Copper-bind | e2hwzL2 | A: alpha bundles | X: Cloacin translocation domain | H: beta-Prism I | T: beta-Prism I | F: Copper-bind | ECOD (develop294) |
| B [auth H] | CsrA | e2hwzH1 | A: alpha bundles | X: HTH | H: Nudix | T: Nudix | F: CsrA | ECOD (develop294) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| A [auth L] | MEDI-493, anti-respiratory syncitial virus fusion protein (F | L-KAPPA | Humanized (humanized) | IGKV1-5*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202610-0) |
| B [auth H] | MEDI-493, anti-respiratory syncitial virus fusion protein (F | VH-CH1 | Humanized (humanized) | IGHV2-70*01, IGHV2-70*13, IGHJ2*01, IGHG1*03 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202610-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| A [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-20) |
| B [auth H] | Heavy Chain | IGHV2 | - | - | SAbDab (2026-03-20) |
| Chain | Name | Target | Provenance Source |
|---|
| A [auth L] | Palivizumab | Respiratory Syncytial Virus Glycoprotein F | Therapeutic SAbDab (2026-03-20) |
| B [auth H] | Palivizumab | Respiratory Syncytial Virus Glycoprotein F | Therapeutic SAbDab (2026-03-20) |